Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
for
Ductal Carcinoma in Situ
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Sex: Female
Age: 18+
Code: NCT05218044
Recruiting
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
for
Waldenstrom Macroglobulinemia
Location: Glendale CA, Duarte CA, Rancho Mirage CA, Las Vegas NV,
Sponsor: BeiGene
Sex: All
Age: 18+
Code: NCT05640102
Recruiting
Optimizing Daily Mindfulness Interventions Using Peer Support to Increase Well-Being in First-Year Students
for
OMI, OMI+, Control Group
Location: Claremont CA
Sponsor: Pitzer College
Sex: All
Age: 18 - 30
Code: NCT04828291
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Glendale CA, Duarte CA, La Jolla CA, Henderson NV,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase 3, Recruiting
New
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Valley Village CA, Irvine CA, Oakland CA, Phoenix AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07775300
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
for
Obesity, Stem Cell Transplant
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 13 - 30
Code: NCT04997473
Recruiting
Clinical Protocol CERN Feasibility Study
for
Bacterial Vaginosis, Fungal Vaginal Infections
Location: Orange CA, Santa Ana CA, Irvine CA
Sponsor: Cern Corporation
Sex: Female
Age: 18+
Code: NCT06933420
Recruiting
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Glendale CA, Athens GA, Pinehurst NC, Baltimore MD
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT05168566
Phase 2, Recruiting
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
for
Moderate Alzheimer Disease
Location: Glendale CA, Santa Ana CA, Maitland FL, Orlando FL,
Sponsor: NKGen Biotech, Inc.
Sex: All
Age: 40 - 70+
Code: NCT06189963
Phase 1, Phase 2, Recruiting
An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging
for
Breast Cancer
Location: Newport Beach CA
Sponsor: Levine, Gary M. , M.D.
Sex: Female
Age: 18+
Code: NCT01379092
Recruiting
New
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
for
Atopic Dermatitis
Location: Huntington Beach CA, Northridge CA, Tulsa OK,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07783425
Phase 3, Recruiting
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
for
Social Anxiety Disorder
Location: Sherman Oaks CA, Walnut Creek CA, Cary NC,
Sponsor: VistaGen Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06809179
Phase 2, Recruiting
New
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
for
Nasal Polyps
Location: Sherman Oaks CA, Plano TX, Greenville SC
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07782957
Phase 3, Recruiting
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis
Location: Duarte CA, Seattle WA, Houston TX, Ann Arbor MI,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04485260
Phase 1, Phase 2, Recruiting
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for
Supratentorial Hemorrhage
Location: Burbank CA, Salt Lake City UT, Seattle WA,